American Public Health Association Annual Meeting ▪ November 3-7, 2007 ▪ Washington, DC

Cooper, H., Friedman, S. R., Brady, J., Tempalski, B., & Gostnell, K. Temporal trends in injection drug user among Black and White adult residents of US metropolitan areas (1992-2002).

Deren, S., Kang, S.-Y., Mino, M., & Guarino, H. Training drug treatment clients to conduct peer outreach: Preliminary outcomes.

Des Jarlais, D. C., Arasteh, K., Hagan, H., McKnight, C., & Friedman, S. R. Herpes simplex virus-2 and HIV among non-injecting drug users in New York City.

Des Jarlais, D. C., Kling, R., Hammett, T., Ngu, D., Liu, W., Chen, Y., Binh, K. T., Friedmann, P. Reducing HIV infection among drug users in the China-Vietnam Cross Border Project.

Friedman, S. R. Dialectical theory and the HIV/AIDS epidemic.

Goldstein, M. F. & Joyner, P. An American Sign Language HIV video survey for deaf adolescents.

Kang, S.-Y., Deren, S., & Mino, M. Biculturality and HIV risk among Puerto Rican drug users in NYC.

Mino, M., Deren, S., & Kang, S.-Y. Chronic health conditions of drug users.

Munoz-Plaza, C. E., Strauss, S. M., Astone-Twerell, J., Des Jarlais, D., Gwadz, M., Hagan, H., & Osborne, A. Changes in hepatitis C virus (HCV) education and counseling delivery practices among drug treatment program staff participating in a targeted training.

Strauss, S. M., Astone-Twerell, J., Munoz-Plaza, C. E., Des Jarlais, D., Gwadz, M., Hagan, H., Osborne, A., & Rosenblum, A. We can help: Changing the drug treatment organization's collective efficacy to support patients' hepatitis C virus (HCV) needs through an on-site staff training.

College on Problems of Drug Dependence ▪ June 16-21, 2007 ▪ Quebec City, Canada

Cleland, C. M., Des Jarlais, D. C., Perlis, T. E., Stimson, G., Poznyak, V., & the WHO Phase II Drug Injection Collaborative Study Group. HIV risk behaviors among female IDUs in developing and transitional countries.

Des Jarlais, D. C., Kling, R., Hammett, T. M., Ngu, D., Liu, W., Chen, Y., Thanh Binh, K., & Friedmann, P. Cross-border HIV prevention for IDUs i Vietnam and China.

Deutscher, M., & Perlman, D. C. Why some injection drug users lick their needles.

Magura. S., Hershberger, J., Rosenblum, A., Joseph, H., Santana, N., Marsch, L. A., Lee, J. D., Shrophshire, C., Glick, A., Liautaud, J. Effectiveness of buprenorphine maintenance in jail: A pilot study.

Marsch, L. A. Evidence-based behavioral and pharmacological treatment of opioid-dependent adolescents.

International Conference on the Reduction of Drug Related Harm ▪ May 13-17, 2007 ▪ Warsaw, Poland

Friedman, S. R. User activism and harm reduction in an age of socioecologial change.

Joseph, H., Rosenblum, A., Magura, S., Lee, J., Marsch, L., Santana, N., Shropshire, C., & Hershberger, J. Introduction of buprenorphine treatment into a large jail system.

Mateu-Gelabert, P., et al. Staying Safe: Exploring some commonalities in how long-term injectors stay negative for both HIV and HCV.

Tempalski, B. Placing the dynamics of syringe exchange programs in the United States.

Tempalski, B., Cooper, H., Friedman, S. R., Des Jarlais, D. C., & Brady, J. Correlates of syringe exchange coverage for heroin injection in 35 large metropolitan areas in the U.S. in which heroin is the dominant injected drug.